News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,353 Results
Type
Article (86752)
Company Profile (704)
Press Release (763895)
Multimedia
Podcasts (140)
Webinars (18)
Section
Business (232777)
Career Advice (4130)
Deals (39749)
Drug Delivery (129)
Drug Development (91065)
Employer Resources (198)
FDA (18162)
Job Trends (17356)
News (396722)
Policy (39801)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (103)
Alliances (56947)
ALS (112)
Alzheimer's disease (1539)
Antibody-drug conjugate (ADC) (186)
Approvals (18113)
Artificial intelligence (378)
Autoimmune disease (35)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (38)
Breast cancer (377)
Cancer (2946)
Cardiovascular disease (236)
Career advice (3537)
Career pathing (34)
CAR-T (200)
CDC (38)
Cell therapy (551)
Cervical cancer (24)
Clinical research (74054)
Collaboration (1052)
Company closure (3)
Compensation (658)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (320)
Cystic fibrosis (117)
Data (2916)
Decentralized trials (2)
Denatured (49)
Depression (66)
Diabetes (358)
Diagnostics (6965)
Digital health (25)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (167)
Drug pricing (149)
Drug shortages (35)
Duchenne muscular dystrophy (126)
Earnings (97422)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131299)
Executive appointments (891)
FDA (19787)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (965)
Gene editing (142)
Generative AI (37)
Gene therapy (419)
GLP-1 (907)
Government (5236)
Grass and pollen (6)
Guidances (180)
Healthcare (20913)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (172)
Immuno-oncology (8)
Indications (38)
Infectious disease (3073)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (64)
Intellectual property (119)
Interviews (813)
IPO (17891)
IRA (54)
Job creations (5192)
Job search strategy (2861)
Kidney cancer (15)
Labor market (54)
Layoffs (582)
Leadership (25)
Legal (10130)
Liver cancer (84)
Lung cancer (417)
Lymphoma (205)
Machine learning (9)
Management (65)
Manufacturing (415)
MASH (92)
Medical device (14695)
Medtech (14700)
Mergers & acquisitions (22536)
Metabolic disorders (913)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (39)
Neuroscience (2254)
NextGen: Class of 2025 (7687)
Non-profit (5088)
Now hiring (48)
Obesity (470)
Opinion (286)
Ovarian cancer (97)
Pain (115)
Pancreatic cancer (114)
Parkinson's disease (192)
Partnered (25)
Patents (301)
Patient recruitment (144)
Peanut (54)
People (65613)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22864)
Phase II (32153)
Phase III (24215)
Pipeline (1613)
Policy (227)
Postmarket research (3552)
Preclinical (10326)
Press Release (72)
Prostate cancer (142)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (499)
Real estate (7399)
Recruiting (75)
Regulatory (27035)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (164)
Series B (108)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (81)
Tariffs (63)
The Weekly (89)
Vaccines (884)
Venture capital (53)
Weight loss (323)
Women's health (48)
Worklife (20)
Date
Today (70)
Last 7 days (526)
Last 30 days (2395)
Last 365 days (34121)
2025 (16892)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (67)
Alaska (7)
Arizona (279)
Arkansas (14)
Asia (50439)
Australia (8867)
California (7514)
Canada (2315)
China (690)
Colorado (322)
Connecticut (340)
Delaware (195)
Europe (115735)
Florida (1106)
Georgia (258)
Hawaii (1)
Idaho (65)
Illinois (716)
India (32)
Indiana (377)
Iowa (18)
Japan (218)
Kansas (115)
Kentucky (32)
Louisiana (17)
Maine (73)
Maryland (1076)
Massachusetts (5757)
Michigan (271)
Minnesota (469)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (73)
New Jersey (2096)
New Mexico (31)
New York (2112)
North Carolina (1217)
North Dakota (10)
Northern California (3239)
Ohio (243)
Oklahoma (16)
Oregon (48)
Pennsylvania (1610)
Puerto Rico (18)
Rhode Island (39)
South America (1653)
South Carolina (35)
South Dakota (1)
Southern California (2767)
Tennessee (123)
Texas (1133)
United States (28417)
Utah (224)
Virginia (202)
Washington D.C. (80)
Washington State (665)
West Virginia (4)
Wisconsin (83)
There are 851,353 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enterome presents positive Phase 2 interim results in relapsed/refractory indolent non-Hodgkin lymphoma after EO2463 OncoMimics™ immunotherapy treatment at ICML
June 23, 2025
·
6 min read
Press Releases
Early data suggest Roche’s NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia A
June 23, 2025
·
8 min read
Press Releases
Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma
June 23, 2025
·
9 min read
Press Releases
Idorsia’s QUVIVIQ expands into China as Simcere receives NDA approval – Idorsia and Simcere update their licensing agreement
June 23, 2025
·
4 min read
Press Releases
Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer
June 23, 2025
·
7 min read
Press Releases
Galapagos Appoints Aaron Cox as Chief Financial Officer
June 23, 2025
·
4 min read
Press Releases
AB Science - New peer-reviewed data provide strong evidence supporting masitinib potential for the treatment of Alzheimer’s disease
June 23, 2025
·
9 min read
Press Releases
Opterion Health AG Appoints Industry Leaders Rice Powell and Mark Hahn to Board of Directors
June 23, 2025
·
3 min read
Press Releases
IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant
June 23, 2025
·
10 min read
Press Releases
DARZALEX® (daratumumab) receives the first positive CHMP opinion for patients with high-risk smouldering multiple myeloma
June 23, 2025
·
13 min read
1 of 85,136
Next
